618 related articles for article (PubMed ID: 37294106)
1. Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
Li D; Xu W; Chang Y; Xiao Y; He Y; Ren S
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(6):956-973. PubMed ID: 37294106
[TBL] [Abstract][Full Text] [Related]
2. MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.
Cheng B; Lai Y; Huang H; Peng S; Tang C; Chen J; Luo T; Wu J; He H; Wang Q; Huang H
Environ Toxicol; 2024 Feb; 39(2):927-941. PubMed ID: 37972062
[TBL] [Abstract][Full Text] [Related]
3. Targeting the prostate tumor microenvironment by plant-derived natural products.
Wu J; Ji H; Li T; Guo H; Xu H; Zhu J; Tian J; Gao M; Wang X; Zhang A
Cell Signal; 2024 Mar; 115():111011. PubMed ID: 38104704
[TBL] [Abstract][Full Text] [Related]
4. Tumour microenvironment and focal therapy for prostate cancer.
Borges RC; Tourinho-Barbosa RR; de la Rosette J
Curr Opin Urol; 2022 May; 32(3):248-253. PubMed ID: 35552306
[TBL] [Abstract][Full Text] [Related]
5. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
6. How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.
Stultz J; Fong L
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):697-717. PubMed ID: 33820953
[TBL] [Abstract][Full Text] [Related]
7. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
8. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
9. A combined signature of glycolysis and immune landscape predicts prognosis and therapeutic response in prostate cancer.
Guo T; Wang J; Yan S; Meng X; Zhang X; Xu S; Ren S; Huang Y
Front Endocrinol (Lausanne); 2022; 13():1037099. PubMed ID: 36339430
[TBL] [Abstract][Full Text] [Related]
10. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.
Mughees M; Kaushal JB; Sharma G; Wajid S; Batra SK; Siddiqui JA
Semin Cancer Biol; 2022 Nov; 86(Pt 3):497-512. PubMed ID: 35181473
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
Heidegger I; Fotakis G; Offermann A; Goveia J; Daum S; Salcher S; Noureen A; Timmer-Bosscha H; Schäfer G; Walenkamp A; Perner S; Beatovic A; Moisse M; Plattner C; Krogsdam A; Haybaeck J; Sopper S; Thaler S; Keller MA; Klocker H; Trajanoski Z; Wolf D; Pircher A
Mol Cancer; 2022 Jun; 21(1):132. PubMed ID: 35717322
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer.
Kang J; La Manna F; Bonollo F; Sampson N; Alberts IL; Mingels C; Afshar-Oromieh A; Thalmann GN; Karkampouna S
Cancer Lett; 2022 Apr; 530():156-169. PubMed ID: 35051532
[TBL] [Abstract][Full Text] [Related]
13. Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review).
Naser R; Fakhoury I; El-Fouani A; Abi-Habib R; El-Sibai M
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579669
[TBL] [Abstract][Full Text] [Related]
14. A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation.
Kerr SC; Morgan MM; Gillette AA; Livingston MK; Lugo-Cintron KM; Favreau PF; Florek L; Johnson BP; Lang JM; Skala MC; Beebe DJ
Integr Biol (Camb); 2020 Oct; 12(10):250-262. PubMed ID: 33034643
[TBL] [Abstract][Full Text] [Related]
15. A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells.
McGovern JA; Bock N; Shafiee A; Martine LC; Wagner F; Baldwin JG; Landgraf M; Lahr CA; Meinert C; Williams ED; Pollock PM; Denham J; Russell PJ; Risbridger GP; Clements JA; Loessner D; Holzapfel BM; Hutmacher DW
Commun Biol; 2021 Aug; 4(1):1014. PubMed ID: 34462519
[TBL] [Abstract][Full Text] [Related]
16. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
17. Complexity of Neural Component of Tumor Microenvironment in Prostate Cancer.
Sejda A; Sigorski D; Gulczyński J; Wesołowski W; Kitlińska J; Iżycka-Świeszewska E
Pathobiology; 2020; 87(2):87-99. PubMed ID: 32045912
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor moonlighting in the prostate cancer microenvironment.
Cioni B; Zwart W; Bergman AM
Endocr Relat Cancer; 2018 Jun; 25(6):R331-R349. PubMed ID: 29618577
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.
El-Tanani M; Rabbani SA; Babiker R; Rangraze I; Kapre S; Palakurthi SS; Alnuqaydan AM; Aljabali AA; Rizzo M; El-Tanani Y; Tambuwala MM
Cancer Lett; 2024 Jun; 591():216894. PubMed ID: 38626856
[TBL] [Abstract][Full Text] [Related]
20. Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.
Akinsipe T; Mohamedelhassan R; Akinpelu A; Pondugula SR; Mistriotis P; Avila LA; Suryawanshi A
Front Immunol; 2024; 15():1302587. PubMed ID: 38533507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
